Global Organ Preservation Market Size By Preservation Technique, By Organ Type (Kidneys, Liver), By End-User (Hospitals and Transplant Centres, Organ Procurement Organizations), By Geographic Scope and Forecast

Organ Preservation Market Size and Forecast

Organ Preservation Market size was valued at USD 259.34 Million in 2024 and is projected to reach USD 414.24 Million by 2032, growing at a CAGR of 6.65% from 2026 to 2032.

Organ preservation refers to the strategies and methods used to ensure the viability and functionality of organs for transplantation or study. This method is critical because organs must be kept in good condition after being removed from a donor to avoid deterioration and ensure they function properly when transplanted into a recipient.

It is a vital technique in transplantation medicine that aims to keep organs viable and functional for transplantation. The principal applications of organ preservation include liver, kidney, heart, lung, and pancreatic transplants. Various preservation strategies, including static cold storage, hypothermic machine perfusion, and normothermic machine perfusion are used to increase organ viability during transport and storage.

The future of organ preservation seems promising, thanks to technical breakthroughs and greater study. Emerging techniques such as biopreservation and the use of synthetic media to keep organs viable at higher temperatures are being investigated to prolong preservation times and improve organ quality.

Global Organ Preservation Market Dynamics

The key market dynamics that are shaping the global organ preservation market include:

Key Market Drivers:

Increasing Organ Transplantation Rates: As the frequency of organ failure from chronic diseases such as diabetes, hypertension, and liver disease rises so does the demand for organ transplants. As more people seek organ transplants, the necessity for efficient organ preservation strategies grows. Improved transplant success rates motivate hospitals and healthcare facilities to invest in enhanced preservation technologies which drives market expansion.

Advances in Preservation Technologies: Innovations in organ preservation technologies such as hypothermic machine perfusion and enhanced cryopreservation procedures have increased organ viability and longevity during storage and transport. These developments increase the likelihood of a successful transplant making preservation technology more enticing to healthcare professionals.

Government Initiatives and Awareness Programs: Governments and organizations around the world are increasingly realizing the value of organ donation and preservation. Initiatives to raise awareness about organ donation, increase donation rates, and introduce improved preservation procedures are becoming more common. Such programs not only encourage more people to register as organ donors but they also promote the use of modern preservation technology in healthcare settings.

Key Challenges:

Limited Availability of Organs: One of the most significant issues in organ preservation is the lack of suitable organs for transplantation. Despite advances in preservation procedures, there is still a considerable gap between organ demand and supply. Factors such as organ donor eligibility, public knowledge, and cultural views toward organ donation all worsen the problem.

Technological Limitations: Although organ preservation technologies like as cold storage and hypothermic machine perfusion have advanced, they are still limited. These techniques can only extend organ viability for a limited time increasing the risk of ischemia and cell damage.

Regulatory and Compliance Issues: The organ preservation industry is highly regulated with strict criteria governing the techniques and goods used. Navigating these restrictions can be difficult and time-consuming for businesses, potentially delaying the adoption of new technologies and increasing operational costs. Compliance with these standards is critical for market participants but it can be difficult, particularly for smaller companies.

Key Trends:

Technological Advancements: New organ preservation procedures such as hypothermic machine perfusion and normothermic regional perfusion are increasing the survivability of organs for transplantation. These innovative procedures not only increase the preservation period but also improve organ function after transplantation.

Increased Demand for Organ Transplants: As chronic diseases like diabetes and liver cirrhosis become more common, there is a greater demand for organ transplants. As waiting lists for organ transplants rise, effective preservation measures become increasingly important. This trend is pushing investment in R&D with a focus on improving organ preservation technologies to satisfy increasing demand.

Regulatory Support and Initiatives: Governments and health organizations are launching programs to encourage organ donation and transplantation. Regulators are also developing rules to encourage the use of advanced preservation technology. Such support improves the entire picture of organ transplantation by enabling better preservation methods and increasing organ availability.

Global Organ Preservation Market Regional Analysis

Here is a more detailed regional analysis of the global organ preservation market:

North America:

North America dominates the organ preservation market owing to its advanced healthcare infrastructure and high organ transplant rates. This dominance is reinforced by significant government financing, extensive research projects, and an established network of organ procurement groups. The United States leads in organ transplantation in North America, with the United Network for Organ Sharing (UNOS) reporting 41,354 organ transplants in 2021, up 5.9% from 2020.

According to data from the Organ Procurement and Transplantation Network (OPTN), there were 104,888 candidates on the national transplant waiting list in February 2023, highlighting the crucial need for organ preservation technology to maximize the viability of available organs. The U.S. Department of Health and Human Services reports that 17 people die each day waiting for an organ transplant emphasizing the urgency for advanced preservation methods to increase the pool of viable organs.

According to the Canadian Institute for Health Information, 2,782 organ transplants were performed in 2021, representing a 13% increase from 2020. The Canadian government has invested CAD 36.5 million over five years to improve the organ donation and transplantation system, which includes funding for preservation technologies.

Asia Pacific:

The rapidly increasing rate of organ transplants is the fastest-growing driver of the Asia Pacific organ preservation market. This acceleration is mostly owing to improved healthcare infrastructure, increased public awareness of organ donation, and government attempts to promote transplantation programs. In China, the number of organ transplants has significantly increased. The Commission also projected that the number of registered organ donors in China will reach 2.54 million by the end of 2020, up from 1,087 in 2010.

According to the National Organ and Tissue Transplant Organisation (NOTTO), the rate of organ donation in India has increased from 0.08 per million people in 2012 to 0.65 per million by 2021. Australia and New Zealand have also helped to drive regional growth, with the Australia and New Zealand Organ Donation Registry reporting 1,444 organ transplants in 2020, despite the pandemic's hurdles. These figures highlight the growing demand for effective organ preservation options in the Asia Pacific region. Furthermore, the World Health Organization estimates that the prevalence of chronic diseases, a primary driver of organ transplantation, will increase by 57% in the Asia Pacific region.

Global Organ Preservation Market: Segmentation Analysis

The Global Organ Preservation Market is segmented based on Preservation Technique, Organ Type, End-User, and Geography.

Organ Preservation Market, By Preservation Technique

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP
• Normothermic Machine Perfusion (NMP)

Based on the Preservation Technique, the Global Organ Preservation Market is bifurcated into Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP, Normothermic Machine Perfusion (NMP). In the global organ preservation market, static cold storage (SCS) remains the dominant technique due to its widespread acceptance and established protocols for preserving organs before transplantation. SCS is cost-effective, simple to implement, and requires minimal equipment making it accessible for many hospitals and transplant centers. It is particularly effective for short-term preservation of organs such as kidneys and livers.

Organ Preservation Market, By Organ Type

• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

Based on the Organ Type, the Global Organ Preservation Market is bifurcated into Kidneys, Liver, and Heart, Lungs, Pancreas, Others. In the global organ preservation market, the kidneys segment is the dominant category. This dominance is primarily due to the high prevalence of kidney diseases including chronic kidney disease and end-stage renal failure which necessitate organ transplants. The increasing number of dialysis patients seeking transplants amplifies the demand for kidney preservation solutions. Additionally, advancements in preservation technologies such as hypothermic machine perfusion, enhance the viability and longevity of kidney transplants, further propelling this segment's growth.

Organ Preservation Market, By End-User

• Hospitals and Transplant Centres
• Organ Procurement Organizations
• Research Institutes and Laboratories

Based on the End-User, the Global Organ Preservation Market is bifurcated into Hospitals and Transplant Centres, Organ Procurement Organizations, Research Institutes and Laboratories. In the global organ preservation market, hospitals and transplant centers are the dominant end-users. This dominance stems from their central role in the organ transplantation process where the preservation of organs is critical for successful outcomes. Hospitals and transplant centers are equipped with specialized facilities and expertise to ensure optimal preservation conditions facilitating the timely transplantation of harvested organs. Moreover, the increasing number of organ transplant procedures due to rising organ failure rates and advancements in transplantation technologies further drive the demand for preservation solutions in these settings.

Organ Preservation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Organ Preservation Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is the dominant region in the global organ preservation market. This leadership is primarily attributed to advanced healthcare infrastructure, high rates of organ transplantation, and significant investments in research and development. The presence of key players and cutting-edge technologies further enhances the region's market position. Additionally, stringent regulations and standards governing organ preservation practices in North America drive innovation and ensure high-quality preservation solutions.

Key Players

The "Global Organ Preservation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are XVIVO Perfusion, TransMedics, OrganOx Limited, Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Preservation Solutions, Inc., BioLifeSolutions, Inc., Bridge to Life Ltd., 21st Century Medicine, and Paragonix Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Organ Preservation Market Key Developments

• In August 2022, Paragonix Technologies, Inc. achieved a critical milestone by preserving over 2,000 donor organs while delivering Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these systems incorporates novel preservation methods, considerably improving traditional ice and cooler processes.
• In January 2023, transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient.